I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 21 studies | 26% ± 9% | |
| natural killer cell | 13 studies | 23% ± 6% | |
| epithelial cell | 8 studies | 34% ± 17% | |
| macrophage | 8 studies | 27% ± 9% | |
| T cell | 7 studies | 20% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 7 studies | 20% ± 4% | |
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 24% ± 4% | |
| microglial cell | 7 studies | 25% ± 8% | |
| fibroblast | 7 studies | 20% ± 3% | |
| astrocyte | 7 studies | 26% ± 10% | |
| myeloid cell | 6 studies | 26% ± 11% | |
| dendritic cell | 6 studies | 22% ± 10% | |
| ciliated cell | 6 studies | 24% ± 8% | |
| pericyte | 6 studies | 23% ± 8% | |
| type II pneumocyte | 6 studies | 19% ± 5% | |
| CD4-positive, alpha-beta T cell | 5 studies | 18% ± 2% | |
| CD8-positive, alpha-beta T cell | 5 studies | 20% ± 3% | |
| endothelial cell of lymphatic vessel | 5 studies | 28% ± 9% | |
| type I pneumocyte | 5 studies | 20% ± 4% | |
| monocyte | 5 studies | 25% ± 6% | |
| club cell | 5 studies | 20% ± 5% | |
| smooth muscle cell | 5 studies | 19% ± 4% | |
| basal cell | 5 studies | 27% ± 14% | |
| leukocyte | 4 studies | 20% ± 4% | |
| non-classical monocyte | 4 studies | 23% ± 8% | |
| effector memory CD8-positive, alpha-beta T cell | 4 studies | 22% ± 2% | |
| adipocyte | 4 studies | 21% ± 4% | |
| mast cell | 4 studies | 18% ± 4% | |
| lymphocyte | 4 studies | 35% ± 9% | |
| classical monocyte | 3 studies | 26% ± 6% | |
| mature NK T cell | 3 studies | 26% ± 7% | |
| B cell | 3 studies | 17% ± 1% | |
| GABAergic neuron | 3 studies | 36% ± 6% | |
| glutamatergic neuron | 3 studies | 32% ± 11% | |
| alveolar macrophage | 3 studies | 32% ± 8% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 21% ± 3% | |
| goblet cell | 3 studies | 35% ± 21% | |
| transit amplifying cell | 3 studies | 35% ± 22% | |
| erythroblast | 3 studies | 19% ± 3% | |
| oligodendrocyte | 3 studies | 20% ± 3% |
